Quelling the data analysis bottleneck while leveraging 4D-Proteomics™ benefits
The 4D-Proteomics™ approaches have reached a level of combined performance, robustness, and reproducibility compatible with large scale clinical research projects. If not taken care of, the data processing stage can be a bottleneck for the full process. In this webinar, Dr. Jonathan Krieger will demonstrate how the Bruker ProteoScape™ platform supports such projects, from high-speed dda and dia based identification and quantification to QC management or DeNovo support, and discuss the latest introduction that have been introduced to improve the large projects handling capabilities.
Presenter: Jonathan Krieger, Ph.D. (Head of Research, Bruker ProteoScape™, Bruker Daltonics, Canada)
Moderator: Pierre-Olivier Schmit (Market Manager Proteomics, Bruker Daltonics, France)
